R Papeschi, P Molina-Negro, T L Sourkes, G Erba. Show Affiliations »
Abstract
Entities: Chemical Disease Gene Species
Mesh: See more » AdolescentAdultBasal Ganglia Diseases/metabolismCerebral Palsy/drug therapyCerebral Ventricles/metabolismDiazepam/therapeutic useDihydroxyphenylalanine/therapeutic useDown Syndrome/drug therapyDown Syndrome/metabolismDystonia Musculorum Deformans/metabolismEpilepsy/metabolismFemaleHumansHydroxyindoleacetic Acid/cerebrospinal fluidInfantMaleMiddle AgedMovement Disorders/metabolismObsessive-Compulsive Disorder/drug therapyObsessive-Compulsive Disorder/metabolismParkinson Disease/drug therapyParkinson Disease/metabolismPhantom Limb/drug therapyPhantom Limb/metabolismPhenylacetates/cerebrospinal fluidPyridoxal Phosphate/therapeutic useSerotonin/metabolismSpinal PunctureTorticollis/drug therapyTorticollis/metabolism
Substances: See more » PhenylacetatesSerotoninHydroxyindoleacetic AcidPyridoxal PhosphateDihydroxyphenylalanineDiazepam
Year: 1972 PMID: 4263829 DOI: 10.1212/wnl.22.11.1151
Source DB: PubMed Journal: Neurology ISSN: 0028-3878 Impact factor: 9.910